Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients

TUESDAY, June 16, 2020 -- In the treatment of COVID-19 patients, chloroquine phosphate or hydroxychloroquine sulfate should not be used with the experimental drug remdesivir because of a potentially unfavorable drug interaction, the U.S. Food and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news